Target Price | $72.42 |
Price | $60.84 |
Potential |
19.03%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target iRadimed Corp 2026 .
The average iRadimed Corp target price is $72.42.
This is
19.03%
register free of charge
$75.60
24.26%
register free of charge
$70.70
16.21%
register free of charge
|
|
A rating was issued by 8 analysts: 7 Analysts recommend iRadimed Corp to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the iRadimed Corp stock has an average upside potential 2026 of
19.03%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 73.24 | 81.02 |
11.71% | 10.62% | |
Net Margin | 26.26% | 27.79% |
0.14% | 5.84% |
4 Analysts have issued a sales forecast iRadimed Corp 2025 . The average iRadimed Corp sales estimate is
This results in the following potential growth metrics:
4 iRadimed Corp Analysts have issued a net profit forecast 2025. The average iRadimed Corp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 1.50 | 1.77 |
11.11% | 18.00% | |
P/E | 34.38 | |
EV/Sales | 8.93 |
4 Analysts have issued a iRadimed Corp forecast for earnings per share. The average iRadimed Corp EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Roth MKM |
Locked
➜
Locked
|
Locked | Feb 14 2025 |
Analyst Rating | Date |
---|---|
Locked
Roth MKM:
Locked
➜
Locked
|
Feb 14 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.